Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.
作者信息
Rob F, Hugo J, Tivadar S, Boháč P, Gkalpakiotis S, Vargová N, Arenbergerová M, Hercogová J
机构信息
Dermatovenereology Department, Second Faculty of Medicine, Na Bulovce Hospital, Charles University, Prague, Czech Republic.
Dermatovenereology Department, Third Faculty of Medicine, Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic.
出版信息
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e682-e684. doi: 10.1111/jdv.16771. Epub 2020 Jul 9.
Abstract
摘要
相似文献
1
Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e682-e684. doi: 10.1111/jdv.16771. Epub 2020 Jul 9.
2
Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China.
Eur J Dermatol. 2020 Dec 1;30(6):738-740. doi: 10.1684/ejd.2020.3908.
3
A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience - Franche Comté, France.
Eur J Dermatol. 2021 Feb 1;31(1):101-103. doi: 10.1684/ejd.2020.3960.
4
Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study.
Acta Derm Venereol. 2019 Apr 1;99(4):386-392. doi: 10.2340/00015555-3108.
5
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
J Cutan Med Surg. 2020 Nov/Dec;24(6):625-632. doi: 10.1177/1203475420945234. Epub 2020 Aug 6.
6
Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.
Dermatol Ther. 2021 Jan;34(1):e14498. doi: 10.1111/dth.14498. Epub 2020 Nov 10.
7
Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto.
J Cutan Med Surg. 2020 Jul/Aug;24(4):424-425. doi: 10.1177/1203475420930226. Epub 2020 Jun 1.
8
Biologic drugs during COVID-19 outbreak.
Int J Dermatol. 2020 Oct;59(10):1293. doi: 10.1111/ijd.15088. Epub 2020 Aug 6.
9
Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.
Dermatol Ther. 2021 Jan;34(1):e14700. doi: 10.1111/dth.14700. Epub 2020 Dec 28.
10
Understanding views of patients on biologics for psoriasis amid the COVID-19 pandemic.
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e249-e251. doi: 10.1111/jdv.17091. Epub 2020 Dec 29.
引用本文的文献
1
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.
Psoriasis (Auckl). 2024 May 14;14:29-38. doi: 10.2147/PTT.S451666. eCollection 2024.
2
A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.
Immun Inflamm Dis. 2023 Nov;11(11):e1063. doi: 10.1002/iid3.1063.
3
The Psoriasis Disability Index in Romanian Psoriasis Patients during COVID-19 Pandemic: Contribution of Clinical and Psychological Variables.
J Clin Med. 2023 Sep 16;12(18):6000. doi: 10.3390/jcm12186000.
4
Treatment Adherence in Dermatology During the COVID-19 Pandemic: A Review.
Cureus. 2023 Jan 24;15(1):e34141. doi: 10.7759/cureus.34141. eCollection 2023 Jan.
5
Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands.
Patient Prefer Adherence. 2023 Jan 19;17:167-174. doi: 10.2147/PPA.S392290. eCollection 2023.
6
Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series.
Cureus. 2022 Jun 16;14(6):e25987. doi: 10.7759/cureus.25987. eCollection 2022 Jun.
7
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.
J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.
8
Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study.
J Cosmet Dermatol. 2022 Jan;21(1):39-47. doi: 10.1111/jocd.14610. Epub 2021 Nov 18.
9
Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e632-e634. doi: 10.1111/jdv.17449. Epub 2021 Jun 24.
10
Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital.
Eur J Dermatol. 2021 Apr 1;31(2):183-191. doi: 10.1684/ejd.2021.4016.
本文引用的文献
1
Should biologics for psoriasis be interrupted in the era of COVID-19?
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
2
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
3
US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
Am J Clin Dermatol. 2016 Feb;17(1):87-97. doi: 10.1007/s40257-015-0169-x.
4
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases.
Adv Ther. 2015 Nov;32(11):983-1028. doi: 10.1007/s12325-015-0256-7. Epub 2015 Nov 7.
5
Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A).
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S467-72. doi: 10.1002/acr.20561.
Zotero 插件